BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34149801)

  • 1. Exploration of the Role of m
    Wei Q; Yang D; Liu X; Zhao H; Yang Y; Xu J; Liu T; Yi P
    Front Genet; 2021; 12():650554. PubMed ID: 34149801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Identification of Critical m
    Xu J; Liu Y; Liu J; Xu T; Cheng G; Shou Y; Tong J; Liu L; Zhou L; Xiao W; Xiong Z; Yuan C; Chen Z; Liu D; Yang H; Liang H; Chen K; Zhang X
    Front Genet; 2020; 11():602485. PubMed ID: 33343639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
    Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
    Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
    Zhang C; Liu J; Guo H; Hong D; Ji J; Zhang Q; Guan Q; Ren Q
    Bioengineered; 2021 Dec; 12(1):3159-3176. PubMed ID: 34187307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
    Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
    Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
    Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
    Jiao J; Jiang L; Luo Y
    Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant Evaluation and Clinical Prognostic Values of M6A RNA Methylation Regulators in Prostate Cancer.
    Zhang Q; Luan J; Song L; Wei X; Xia J; Song N
    J Cancer; 2021; 12(12):3575-3586. PubMed ID: 33995635
    [No Abstract]   [Full Text] [Related]  

  • 9. m
    Chen L; Hu B; Song X; Wang L; Ju M; Li Z; Zhou C; Zhang M; Wei Q; Guan Q; Jiang L; Chen T; Wei M; Zhao L
    Front Oncol; 2021; 11():598017. PubMed ID: 33796449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A newly defined risk signature, consisting of three m
    Fan L; Lin Y; Lei H; Shu G; He L; Yan Z; Rihan H; Yin G
    Aging (Albany NY); 2020 Sep; 12(18):18453-18475. PubMed ID: 32950970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma.
    Du J; Hou K; Mi S; Ji H; Ma S; Ba Y; Hu S; Xie R; Chen L
    Front Oncol; 2020; 10():208. PubMed ID: 32211315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer.
    Zhu W; Zhao L; Kong B; Liu Y; Zou X; Han T; Shi Y
    Ann Transl Med; 2022 Jan; 10(2):59. PubMed ID: 35282121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma.
    Wang Y; Ren F; Song Z; Wang X; Ma X
    J Cancer; 2020; 11(21):6390-6401. PubMed ID: 33033522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m
    Zhuang J; Lin C; Ye J
    J Cell Physiol; 2020 Sep; 235(9):6300-6306. PubMed ID: 32043594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma.
    Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X
    Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m
    Fang F; Wang P; Huang H; Ye M; Liu X; Li Q
    BMC Cancer; 2022 Dec; 22(1):1364. PubMed ID: 36581816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m
    Su Y; Huang J; Hu J
    Front Oncol; 2019; 9():1038. PubMed ID: 31681576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of m
    Wang J; Zhang C; He W; Gou X
    Front Oncol; 2020; 10():3. PubMed ID: 32038982
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiles of m
    Li W; Chen QF; Huang T; Shen L; Huang ZL; Wu P
    Oncol Lett; 2020 Apr; 19(4):3296-3306. PubMed ID: 32256825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.